Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intra-specific variations in Schistosoma mansoni and their possible contribution to inconsistent virulence and diverse clinical outcomes.
Dannenhaus TA, Winkelmann F, Reinholdt C, Bischofsberger M, Dvořák J, Grevelding CG, Löbermann M, Reisinger EC, Sombetzki M. Dannenhaus TA, et al. Among authors: lobermann m. PLoS Negl Trop Dis. 2024 Oct 28;18(10):e0012615. doi: 10.1371/journal.pntd.0012615. eCollection 2024 Oct. PLoS Negl Trop Dis. 2024. PMID: 39466851 Free PMC article.
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. JHEP Rep. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 39006503 Free PMC article.
Establishment of a national travel medicine vaccination network to assess reactogenicity of new and rarely used vaccines: a TropNet study.
Köpke C, Rothe C, Zeder A, Boecken G, Feldt T, Janke C, Jordan S, Löbermann M, Müller A, Orth HM, Prüfer-Krämer LM, Schäfer J, Slesak G, Stich A, Bélard S, Thul N, Becker SL, Schneitler S; TravVacNet-Group. Köpke C, et al. Among authors: lobermann m. J Travel Med. 2024 Dec 10;31(8):taae092. doi: 10.1093/jtm/taae092. J Travel Med. 2024. PMID: 38970355 No abstract available.
Utilization of a highly adaptable murine air pouch model for minimally invasive testing of the inflammatory potential of biomaterials.
Woitschach F, Kloss M, Kischkel S, Macháček T, Reinholdt C, Senz V, Schlodder K, Löbermann M, Grabow N, Reisinger EC, Sombetzki M. Woitschach F, et al. Among authors: lobermann m. Front Bioeng Biotechnol. 2024 Apr 26;12:1367366. doi: 10.3389/fbioe.2024.1367366. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38737540 Free PMC article.
Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study.
Fneish F, Frahm N, Peters M, Ellenberger D, Haas J, Löbermann M, Pöhlau D, Röper AL, Schilling S, Stahmann A, Temmes H, Paul F, Zettl UK. Fneish F, et al. Among authors: lobermann m. Vaccines (Basel). 2023 Dec 16;11(12):1859. doi: 10.3390/vaccines11121859. Vaccines (Basel). 2023. PMID: 38140262 Free PMC article.
Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study.
Frahm N, Fneish F, Ellenberger D, Haas J, Löbermann M, Peters M, Pöhlau D, Röper AL, Schilling S, Stahmann A, Temmes H, Paul F, Zettl UK. Frahm N, et al. Among authors: lobermann m. J Clin Med. 2023 May 24;12(11):3640. doi: 10.3390/jcm12113640. J Clin Med. 2023. PMID: 37297838 Free PMC article.
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.
Dietz J, Müllhaupt B, Buggisch P, Graf C, Peiffer KH, Matschenz K, Schattenberg JM, Antoni C, Mauss S, Niederau C, Discher T, Trauth J, Dultz G, Schulze Zur Wiesch J, Piecha F, Klinker H, Müller T, Berg T, Neumann-Haefelin C, Berg CP, Zeuzem S, Sarrazin C; German HCV Resistance Study Group; University Hospitals; Academic Hospitals; Local study sites (private practices), Germany. Dietz J, et al. J Hepatol. 2023 Jan;78(1):57-66. doi: 10.1016/j.jhep.2022.08.016. Epub 2022 Aug 27. J Hepatol. 2023. PMID: 36031158
[Mediastinal Lymphadenopathy - Tuberculosis or Tularemia?].
Geerdes-Fenge HF, Löbermann M, Warnke P, Zimpfer A, Reisinger EC. Geerdes-Fenge HF, et al. Among authors: lobermann m. Laryngorhinootologie. 2022 Jul;101(7):594-596. doi: 10.1055/a-1089-3970. Epub 2022 Jun 23. Laryngorhinootologie. 2022. PMID: 35738272 German. No abstract available.
Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets.
Gold R, Fätkenheuer G, Hartung HP, Kleinschnitz C, Marks R, Maschke M, Bayas A, Löbermann M, Zettl UK, Wiendl H. Gold R, et al. Among authors: lobermann m. Ther Adv Neurol Disord. 2021 Jul 22;14:17562864211019598. doi: 10.1177/17562864211019598. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34671422 Free PMC article. Review.
58 results